2nd Circ. Won't Revive Apotex's Unfair Competition Suit
By Matthew Perlman ( October 26, 2020, 7:53 PM EDT) -- A Second Circuit panel has refused to revive Apotex Corp.'s claims accusing Pfizer unit Hospira of violating unfair competition and other state laws in part by reneging on a promise to keep supplying it with a generic antibiotic....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.